Heart drug shows promise for adults born with heart defects
NCT ID NCT06260059
Summary
This study is testing whether a heart failure medication called Empagliflozin (Jardiance) can help adults who were born with heart defects. Researchers want to see if taking this once-daily pill for one year improves heart function, reduces hospital visits, and eases symptoms like shortness of breath. The study will enroll 40 adults whose heart function has recently declined.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Children's Hospital of Pittsburgh
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
Contact Email: •••••@•••••
-
Magee Women's Hospital
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Email: •••••@•••••
-
Presbyterian Hospital
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.